To be safe, try not to pair your B12 with very heavy, highfat, or extremely highfiber meals, which can slow digestion and may affect how quickly your supplement is absorbed
July 27, 2026: FDA peptide panel narrowly votes to add unapproved drugs to compounding list Major Stories The FDAs peptide panel voted to add six unapproved compounds to the 503A bulks compounding list, despite agency scientists' warnings about the consequences
Catalog skews toward GH-axis, metabolic and cognitive research peptides with higher per-vial concentrations
The Upcoming PCAC Meeting The FDA notice confirms that the PCAC will convene this summer to evaluate whether to recommend the following seven bulk drug substances for inclusion on the 503A bulks list: July 23, 2026: BPC-157 (free base / acetate) KPV (free base / acetate) Thymosin Beta-4, Fragment (LKKTETQ) (TB-500) (free base / acetate) MOTs-C (free base / acetate) July 24, 2026: Emideltide (DSIP) (free base / acetate) Semax (free base / acetate) Epitalon (free base / acetate) All seven substances are of considerable interest to compounding pharmacies, prescribers, and patients
Dermatology-research models simulating microneedling, laser, and chemical-peel injuries have reported shorter erythema duration and accelerated barrier recovery with GHK-Cu application